The duration of effects varies by individual, but most people experience benefits for 1-2 weeks after a single session
Always work with gloves in an environment with minimal airflow to reduce the risk of contamination
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
doi: 10.2139/ssrn.5570323 57 YiSZhengBZhuYCaiYSunHZhouJ
This test is considered an early warning system for a vitamin B12 deficiency because it exclusively detects the biologically active form of the vitamin
Researchers are exploring its potential across a sprawling landscape of applications, primarily focused on its regenerative and cytoprotective (cell-protecting) properties
